About Contact Us Careers
Sign In

Sleep Apnea Devices Market Size & Share, by Disease Type (Obstructive, Central, Complex Sleep Apnea Syndrome), Product Type (Diagnostic Devices, Therapeutic Devices, Sleep Apnea Masks), Patient Demographics (Pediatric, Adult, Geriatric), End-user (Hospital, Diagnostics Centers, Ambulatory Care Centers, Specialty Care Centers, Home Healthcare), Distribution Channel (Direct Tender, Retail Sales) - SWOT Analysis, Competitive Strategic Insights, Regional Trends 2025-2037

  • Report ID: 183
  • Published Date: Jan 17, 2025
  • Report Format: PDF, PPT

Global Sleep Apnea Devices Market Trends, Forecast Report 2025-2037

Sleep Apnea Devices Market size is expected to grow from USD 10.38 billion to USD 25.51 billion, registering a CAGR of more than 7.1% during the forecast timeline, between 2025 and 2037. In the year 2025, the industry size of sleep apnea devices is estimated at USD 10.98 billion.

Market growth is primarily driven by increased prevalence of chronic conditions which is expected to increase the load of OSA. Comorbidities such as diabetes, hypertension, cardiovascular diseases, and obesity are commonly associated with OSA. According to World Health Organization, globally, around 17.9 million people cave in to death to cardiovascular problem.

Sleep Apnea is a sleeping disorder in which the patient faces, pauses in breathing or periods of shallow breathing during sleep occur more often than normal, and it can happen numbers of time in a night. Without treatment, sleep apnea may increase the risk of heart attack, stroke, diabetes, heart failure, irregular heartbeat, and obesity. According to World Health Organization, more than 1 billion people worldwide are obese - 650 million adults, 340 million adolescents and 39 million children.

Get more information on this report: Request Free Sample PDF

Sleep Apnea Devices Sector: Growth Drivers and Challenges

Growth Drivers

  • Growing Demand for Home Sleep Apnea Tests – According to data from the American Sleep Association, nearly 50 million to 70 million U.S. adults have a sleep disorders, of which, 25 million are suffering from obstructive sleep apnea.
  • Rising Prevalence of Obesity to Increase Diagnosis Rate for Sleep Apnea – According to the article published by American Heart Association, Inc., several cross-sectional studies have estimated that significant sleep apnea is present in 40% of the obese population, and 70% of the OSA patients are obese.
  • Advanced Innovation in Technology for Sleep Apnea Devices - As per the data by the World Bank, 2.33% of the global GDP was spent on research and development activities in 2019, which increased to 2.63% in 2020.
  • Increasing Access to Health Care and Health Expenditures- As per the data by the World Bank, 9.83% of the global GDP was spent on health expenditure in 2019.

Challenges

  • High Cost of Devices and Long Waiting Periods
  • Lack of Patient Compliance to Device Therapies

Sleep Apnea Devices Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

7.1%

Base Year Market Size (2024)

USD 10.38 billion

Forecast Year Market Size (2037)

USD 25.51 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Sleep Apnea Devices Segmentation

Product Type (Diagnostic Devices, Therapeutic Devices, Sleep Apnea Masks)

The sleep apnea masks are anticipated to hold the largest sleep apnea devices market size by the end of 2037. The segment growth is primarily attributed to rising prevalence of comorbidities associated with obstructive sleep apnea (OSA), and rising adoption rates of CPAP machines in disease management. As per research, it is estimated that 936 million adults aged 30-69 years (men and women) have mild to moderate obstructive sleep apnea and over 425 million adults aged 30-69 years have moderate to severe obstructive sleep apnea globally.

 

Our in-depth analysis of the global market includes the following segments:

          By Disease Type
  • Obstructive Sleep Apnea Syndrome
  • Central Sleep Apnea Syndrome
  • Complex Sleep Apnea Syndrome

          By Product Type
  • Diagnostic Devices
  • Therapeutic Devices
  • Sleep Apnea Masks

           By Patient Demographics
  • Pediatric
  • Adult
  • Geriatric

          By End User
  • Hospital
  • Diagnostics Centers
  • Ambulatory Care Centers
  • Specialty Care Centers
  • Home Healthcare

          By Distribution Channel
  • Direct Tender
  • Retail Sales

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Sleep Apnea Devices Industry - Regional Synopsis

Asia Pacific is projected to hold largest market share by the end of 2037, owing to growing geriatric population and rising prevalence of diseases such as cardiovascular diseases, cancer, hypertension, and diabetes. According to International Diabetes Federation (IDF), in 2021, 90 million adults were diagnosed with diabetes in South-East Asia region.

Research Nester
Get more information on this report: Request Free Sample PDF

Companies Dominating the Sleep Apnea Devices Market

    • Philips Respironics
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • BMC Medical Co. ltd.
    • Curative Medical Inc.
    • SOMNOmedics GmbH
    • Itamar Medical Ltd.
    • Nihon Kohden Corporation
    • ResMed INC.
    • Natus Medical Incorporated
    • Invacare Corporation
    • Compumedics Limited.

     

In the News

  • ResMed launches AirSense 11 PAP series, advancing digital health in sleep apnea treatment. New digital features designed to make therapy setup and nightly use easier for patients.
  • Nihon Kohden announced the launch of POLYSMITH 12 polysomnography software, driven features that offer sleep specialists improved workflow, analysis and outcomes.

Author Credits:  Radhika Pawar


  • Report ID: 183
  • Published Date: Jan 17, 2025
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of sleep apnea devices is estimated at USD 10.98 billion.

The sleep apnea devices market size was valued at USD 10.38 billion in 2024 and is set to cross USD 25.51 billion by the end of 2037, registering more than 7.1% CAGR during the forecast period i.e., between 2025-2037. Growing demand for home sleep apnea tests and advanced innovations in technology for devices will boost the market growth.

Asia Pacific industry is likely to hold majority revenue share by 2037, propelled by growing geriatric population along with rising prevalence of diseases such as cardiovascular diseases, cancer, hypertension, and diabetes in the region.

The major players in the market include Philips Respironics, BMC Medical Co. ltd., Curative Medical Inc., SOMNOmedics GmbH, Itamar Medical Ltd., Nihon Kohden Corporation, ResMed INC., Natus Medical Incorporated, Invacare Corporation, Compumedics Limited.
Sleep Apnea Devices Market Report Scope

Copyright © 2025 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample